Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC
Clinical trial NCT04821622 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04821622
- Sponsor
- Pfizer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-12
- Primary completion
- 2026-02-18
- Enrollment
- 599
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.